Menu Close

Pain

The Pain Experience

based on : https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/drugs-of-dependence/part-c2/approach-to-pain-management

Definition and Types of Pain:

  • Pain Definition: Pain is described by the International Association for the Study of Pain (IASP) as an unpleasant sensory and emotional experience linked to actual or potential tissue damage.
  • Acute Pain: Results from actual or threatened tissue damage and activates nociceptors.
  • Chronic Pain: Persistent or recurrent pain lasting typically three months or more, including conditions like fibromyalgia, non-specific back pain, osteoarthritis, headaches, chronic cancer pain, and chronic post-surgical pain.

Biopsychosocial Model of Pain:

  • The understanding of pain has evolved from a simple biomedical model to a comprehensive biopsychosocial approach, recognizing that pain is influenced by biomedical, psychological, and social factors. In chronic non-cancer pain (CNCP), social and psychological factors often dominate.

Individual Pain Experience:

  • Pain and disability levels vary greatly among individuals with similar injuries.
  • Responses to pain relief methods also vary individually.
  • Communicating the pain experience can be challenging for patients, leading to frustration and distress.

Management of Pain:

  • Effective pain management requires considering patients’ beliefs, needs, and expectations.
  • Pain affects many aspects of a patient’s life, including daily activities, leisure, and sleep.
  • Severe pain often correlates with a lower quality of life, with pain reduction being a primary goal for many patients.
  • Building a collaborative partnership between patient and GP is crucial, emphasizing empathy and understanding.

Patient-Doctor Relationship:

  • Patients need to feel their pain is understood and validated.
  • It’s important to show interest in the patient as a person, not just their symptoms.
  • Patients’ opinions on pain management should be valued.
  • Optimism about improving their condition is essential.

Role of the GP:

  • Patients may struggle with the involvement of multiple healthcare professionals, leading to confusion.
  • Having a primary care doctor, ideally a GP, who knows the patient’s medical history and can coordinate care is important for effective management of chronic pain.

Placebo Effects:

  • Placebo: A substance or procedure without inherent ability to produce an expected effect, but can have similar profiles to non-placebos.
  • Placebo Response: Therapeutic response to a known placebo.
  • Placebo Effect: Part of the therapeutic response not attributable to active ingredients, influenced by sociocultural treatment context.

Determinants of Placebo Effects:

  • Influenced by doctor-patient relationship, expectancy, classical conditioning, and social/observational learning.
  • Variability exists in degree and duration of placebo effects.

Pathways for Placebo Effects:

  • Higher placebo analgesia when induced via suggestion combined with conditioning.
  • Mediated by endogenous opioids, cholecystokinin, endogenous cannabinoid systems, and dopamine release.

Ethical Considerations and Practical Use:

  • Placebos should not be administered deceptively.
  • Using placebo effects to augment active treatments is becoming less contentious.
  • More clinical research is needed to determine the practical value of placebos.
  • Practitioners should consider how they deliver information to harness placebo effects and optimize treatment outcomes.

Pathophysiology-based Classification

Nociceptive Pain

  • Definition: Arises from actual or threatened damage to non-neural tissue.
  • Function: Guards against tissue injury and supports healing.
  • Subtypes:
    • Visceral Pain: Stimulation of nociceptors within the viscera.
    • Somatic Pain: Stimulation of nociceptors in the musculoskeletal system.
  • Duration: Typically lasts with continual noxious stimuli and resolves after tissue injury resolution.
  • Chronic Nociceptive Pain: May occur in diseases like rheumatoid arthritis.

Neuropathic Pain

  • Definition: Caused by a lesion or disease of the somatosensory nervous system.
  • Causes: Mechanical trauma, metabolic diseases, neurotoxic chemicals, infection, tumor invasion.
  • Diagnostic Criteria:
    • Appropriate history.
    • Signs of neurological deficit.
    • Diagnostic interventions.
    • Confirmation of underlying cause.
  • Chronic Neuropathic Pain: Heterogeneous group of conditions.
  • Co-occurrence: Nociceptive and neuropathic pain may coexist.
  • Treatment: Less than ideal, with fewer than 50% achieving satisfactory relief.

Nociplastic Pain

  • Definition: Pain from altered nociceptive processing without clear evidence of tissue damage or somatosensory system disease.
  • Conditions: Fibromyalgia, complex regional pain syndrome (CRPS), non-specific chronic low back pain, functional visceral pain disorders.
  • Mechanism: Altered function of nociceptive pathways.

Psychophysiological Approach

  • Examined the influence of mental events on physical changes producing pain.
  • General arousal models suggested prolonged ANS arousal and muscular contractions generate and perpetuate pain.
  • Treatments like EMG, biofeedback, and relaxation techniques aim to reduce muscular tension and ANS arousal.

Current Theoretical Models

  • Many acute musculoskeletal injuries do not resolve quickly, leading to chronic pain.
  • Early intervention improves outcomes.
  • The “Yellow Flags” concept screens for risk factors in developing chronic pain.
  • Pincus et al. proposed an Integrated Biopsychosocial Risk-for-Disability Model, combining cognitive and behavioral factors.

Pain-Related Fear and Disability

  • Acute pain associated with anxiety responses; chronic pain linked to vegetative signs of depressive disorders.
  • Fear of pain can be more disabling than pain itself.
  • Pain-related fear predicts performance and disability levels, with avoidance behaviors leading to physical deconditioning and chronicity.
  • Chronic pain may result in physical deconditioning, lowering pain thresholds, and increasing the likelihood of avoiding activities.

Catastrophic Thinking and Pain-Related Fear

  • Catastrophic thinking involves exaggerated orientation towards pain stimuli.
  • Negative appraisals about pain can lead to persistent pain.
  • Pain-related fear interferes with cognitive functions, leading to hyper-vigilance and difficulty shifting attention away from pain-related information.

Pain History Taking

General Assessment and Pain-Specific History

  • Thorough History
    • Chronic pain evaluation is crucial.
    • Pain assessment as the “fifth vital sign.”
    • Familiarity with the patient and input from families/support systems.
  • Pain Characteristics
    • Location
    • Radiation
    • Intensity
    • Quality (sharp, dull, squeezing, throbbing, colicky)
    • Temporal aspects (duration, onset, changes since onset)
    • Constancy or intermittency
    • Breakthrough pain characteristics
    • Exacerbating/triggering factors
    • Relieving factors
    • Associated symptoms:
      • Restricted range of motion, stiffness, swelling
      • Muscle aches, cramps, spasms
      • Color or temperature changes
      • Changes in sweating, skin, hair, or nail growth
      • Changes in muscle strength or sensation (dysesthesias/itching, numbness)

Psychosocial History Taking and Assessment

Pain Impact on Function and Quality of Life

  • Social and Recreational Activities Interference with hobbies, socializing, travel
  • Mood, Affect, and Anxiety Impact on energy, mood, personality
  • Relationships Effect on family, friends, colleagues
  • Occupation Impact on work responsibilities, hours, or cessation of work
  • Sleep Interference with sleep
  • Exercise Interference with exercise activities
  • Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs)
    • Bathing, dressing, toileting, feeding
    • Shopping, using transportation, meal preparation, housework, managing finances and medications

Social Assessment

  • Influences Family, work, life events, housing, sleep, activity, and nutrition
  • Social Participation
    • Participation in pleasurable activities (hobbies, movies, concerts, socializing, travel)
    • Frequency of pain interference over the past week
  • Mood and Relationships
    • Pain’s impact on energy, mood, personality, and tearfulness
    • Effect on relationships with family, significant others, friends, colleagues
  • Occupational Impact
    • Modification of work responsibilities and/or hours due to pain
    • Time since last worked and reasons for stopping work
  • Sleep and Exercise
    • Pain interference with sleep and exercise
    • Frequency of exercise and pain interference over the past week
  • Isolation and Pain-Depression Cycle
    • Social interactions, occupational performance, self-care
    • Use of pain for sympathy, protection, benefits, or medico-legal compensation

Psychological Assessment

  • Behavioral Assessment
    • Explore patient’s personal and family history and support system
    • Inquire about psychological disorders and substance abuse history
    • Patient’s beliefs about pain and healthcare experiences
  • Patient Perceptions
    • Causes of persistent pain
    • Adequacy of diagnostic work-up
    • Expectations for specific treatments
    • Goals for treatment (pain relief and functional improvement)
    • Involvement in treatment planning and execution
  • Mood State, Beliefs, Coping Skills
    • Explore patient’s mood, beliefs, coping skills, behaviors, and responses contributing to pain experience
    • Identify obstacles to recovery and treatment outcome
  • Psychological Factors
    • Use screening tools for mood and anxiety disorders
    • Anxiety as a predictive factor for postoperative pain severity
    • Association between chronic postsurgical pain (CPSP) and depression
    • Relevant beliefs about diagnosis, prognosis, and treatment expectations
    • Fear of pain contributing to avoidance responses and potential disability
    • Negative, ruminative, and helpless thinking styles (e.g., catastrophic thinking)

Physical Examination

  • Assessment for Signs of Tissue Damage/Injury or Disease
    • Signs of nociceptive and/or neuropathic mechanisms of pain (e.g., tissue deformity, inflammation, neural disease or damage)
  • Evaluation of Referred Pain Sources
    • Including visceral sources
  • Observations
    • Hypervigilance or guarding with particular movements
    • Compensatory postures and movements
    • Evidence of allodynia, hypoalgesia, hyperalgesia
  • Provisional Diagnosis
    • Establish diagnosis for pain and biomedical mechanism involved
    • Analyze disability level of the patient

Measurement of Pain and Functional Impact

  • Pain Scoring Systems
    • Verbal numerical rating scales for simplicity and consistency
    • PEG scale for chronic musculoskeletal pain in general practice
    • PEG scale scores (out of 30) as reference points for patient’s overall wellbeing
    • Use of pain scores to compare patient assessments over time

Risk Assessment for Opioid Prescription

  • Careful Prescription of Opioids: Opioids are effective analgesics but require careful prescribing to limit risks such as inappropriate use and diversion.
  • High-Risk Groups for Problematic Opioid Usage:
    • Younger Patients: Substance use issues generally commence before 35 years of age.
    • Patients Without Definite Patho-Anatomic Diagnosis: Lack of clear diagnosis increases misuse risk.
    • Patients with Active Substance Use Problems: Includes those in contact with individuals with substance use problems.
    • Patients with Active Psychiatric Problems: Increases risk of misuse and side effects.
    • Patients Using Benzodiazepines: Concomitant use substantially increases risks of cognitive impairment, sedation, and respiratory depression.
  • Comprehensive Assessment:
    • Address the risk of opioid misuse through thorough patient evaluation.
    • Screening for opioid risk is recommended but lacks strong evidence of effectiveness.
    • Treatment agreements and urine testing are recommended but have not significantly reduced opioid prescribing, misuse, or overdose rates.
  • Patients with History of Substance Use Disorder (SUD):
    • Higher risk of harm from opioids.
    • Check state-based prescription monitoring systems.
    • Generally, avoid offering opioids in general practice settings; refer to specialist services if pain control is unachievable by other means.
  • Urine Drug Screening (UDS):
    • May reveal substances unknown to the practitioner.
    • Not all substances are routinely tested (e.g., specific request needed for oxycodone testing).
    • If unexpected drugs (illicit or legal) are found, refer the patient for specialist assessment and management.
    • Contact local pathology provider for necessary testing.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.